Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression

Journal of Clinical Psychiatry

Volumn 79, Issue 1, 2018, Pages 35-48

  McClintock, Shawn M ^a,b   Reti, Irving M ^c   Carpenter, Linda L ^d   McDonald, William M ^e   Dubin, Marc ^f   Taylor, Stephan F ^g   Cook, Ian A ^h   O'Reardon, John ⁱ   Husain, Mustafa M ^a,b   Wall, Christopher ^j   Krystal, Andrew D ^b,k   Sampson, Shirlene M ^l   Morales, Oscar ^m   Nelson, Brent G ⁿ   Latoussakis, Vassilios ^f   George, Mark S ^o,p   Lisanby, Sarah H ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BUTLER HOSPITAL   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Rowan University School of Medicine ^*  (United States)

^j PrarieCare   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l MAYO CLINIC   (United States)

^m MCLEAN HOSPITAL   (United States)

ⁿ UNIVERSITY OF MINNESOTA   (United States)

^o MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^p RALPH H JOHNSON VA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ACCREDITATION; COMORBIDITY; CONSENSUS DEVELOPMENT; DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; FAINTNESS; HEADACHE; HUMAN; HYPOMANIA; MAINTENANCE THERAPY; MAJOR DEPRESSION; MANIA; MEDICAL DOCUMENTATION; MEDICAL EDUCATION; MEDICAL SOCIETY; PATIENT SAFETY; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; REMISSION; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; REVIEW; SCIENTIST; SEIZURE; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; CONSENSUS; CONTRAINDICATION; PRACTICE GUIDELINE; PROCEDURES; TRANSCRANIAL MAGNETIC STIMULATION;

CONSENSUS; CONTRAINDICATIONS; DEPRESSIVE DISORDER, MAJOR; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 85041748960     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.16cs10905     Document Type: Review

References (118)

1. Rush AJ, Trivedi MH, Wisniewski SR, et al; STARD Study Team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354(12):1231-1242. PubMed doi:10.1056/NEJMoa052963
2. Greden JF. The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry. 2001;62(suppl 22):5-9. PubMed
3. Janicak PG, O'Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry. 2008;69(2):222-232. PubMed doi:10.408/JCP.v69n0208
4. Wassermann EM, Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther. 2012;133(1):98-107. PubMed doi:10.1016/j.pharmthera.201.09.03
5. Salomons TV, Dunlop K, Kennedy SH, et al. Resting-state cortico-thalamic-striatal connectivity predicts response to dorsomedial prefrontal rTMS in major depressive disorder. Neuropsychopharmacology. 2014;39(2): 488-498. PubMed doi:10.1038/np.2013.2
6. Liston C, Chen AC, Zebley BD, et al. Default mode network mechanisms of transcranial magnetic stimulation in depression. Biol Psychiatry. 2014;76(7):517-526. PubMed doi:10.1016/j.biopsych.2014.01.023
7. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1(8437):1106-1107. PubMed doi:10.1016/S0140-6736(85)92413-4
8. Barker AT, Freeston IL, Jabinous R, et al. Clinical evaluation of conduction time measurements in central motor pathways using magnetic stimulation of human brain. Lancet. 1986;1(8493):1325-1326. PubMed doi:10.1016/S0140-6736(86)91243-2
9. George MS, Wassermann EM, Williams WA, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 1995;6(14): 1853-1856. PubMed doi:10.1097/01756-1951020-08
10. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a shamcontrolled randomized trial. Arch Gen Psychiatry. 2010;67(5):507-516. PubMed doi:10.101/archgenpsychiatry.2010.46
11. Holtzheimer PE III, McDonald WM. A Clinical Guide to Transcranial Magnetic Stimulation. New York, NY: Oxford University Press; 2014. doi:10.1093/med/97801926480.01.01
12. Levinson AJ, Fitzgerald PB, Favalli G, et al. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry. 2010;67(5):458-464. PubMed doi:10.1016/j.biopsych.209.09.025
13. Hutton TM. The clinical application of transcranial magnetic stimulation. Psychiatr Ann. 2014;44(6):305-309. doi:10.3928/0485713-20140609-09
14. Cook IA, Espinoza R, Leuchter AF. Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurg Clin N Am. 2014;25(1):103-116. PubMed doi:10.1016/j.nec.2013.10.02
15. Nguyen K-H, Gordon LG. Cost-effectiveness of repetitive transcranial magnetic stimulation versus antidepressant therapy for treatmentresistant depression. Value Health. 2015;18(5):597-604. PubMed doi:10.1016/j.jval.2015.04.04
16. Simpson KN, Welch MJ, Kozel FA, et al. Costeffectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Adv Ther. 2009;26(3):346-368. PubMed doi:10.107/s12325-09-013-x
17. Sackeim HA. Acute continuation and maintenance treatment of major depressive episodes with transcranial magnetic stimulation. Brain Stimulat. 2016;9(3):313-319. PubMed doi:10.1016/j.brs.2016.03.06
18. Connolly KR, Helmer A, Cristancho MA, et al. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J Clin Psychiatry. 2012;73(4):e567-e573. PubMed doi:10.408/JCP.1m07413
19. Lefaucheur JP, André-Obadia N, Antal A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125(11):2150-2206. PubMed doi:10.1016/j.clinph.2014.05.021
20. Schlaepfer TE, George MS, Mayberg H; WFSBP Task Force on Brain Stimulation. WFSBP guidelines on brain stimulation treatments in psychiatry. World J Biol Psychiatry. 2010;11(1):2-18. PubMed doi:10.3109/1562970903170835
21. Perera T, George MS, Grammer G, et al. The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimulat. 2016;9(3):336-346. PubMed doi:10.1016/j.brs.2016.03.010
22. Chistyakov AV, Kreinin B, Marmor S, et al. Preliminary assessment of the therapeutic efficacy of continuous theta-burst magnetic stimulation (cTBS) in major depression: a double-blind sham-controlled study. J Affect Disord. 2015;170:225-229. PubMed doi:10.1016/j.jad.2014.08.035
23. Bakker N, Shahab S, Giacobbe P, et al. rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation. Brain Stimulat. 2015;8(2):208-215. PubMed doi:10.1016/j.brs.2014.1.02
24. Berlim MT, van den Eynde F, Tovar-Perdomo S, et al. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44(2):225-239. PubMed doi:10.1017/S032917130512
25. Kedzior KK, Reitz SK, Azorina V, et al. Durability of the antidepressant effect of the highfrequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials. Depress Anxiety. 2015;32(3):193-203. PubMed doi:10.102/da.239
26. Levkovitz Y, Isserles M, Padberg F, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry. 2015;14(1):64-73. PubMed doi:10.102/wps.2019
27. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216. PubMed doi:10.1016/j.biopsych.207.01.018
28. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report. Am J Psychiatry. 2006;163(11):1905-1917. PubMed doi:10.176/ajp.206.163.1.1905
29. McGirr A, Van den Eynde F, Tovar-Perdomo S, et al. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial. J Affect Disord. 2015;173(1):216-220. PubMed doi:10.1016/j.jad.2014.10.068
30. Ge S, Jiang R, Wang R, et al. Design of a dynamic transcranial magnetic stimulation coil system. J Med Syst. 2014;38(8):64. PubMed doi:10.107/s10916-014-064-7
31. Bretlau LG, Lunde M, Lindberg L, et al. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, shamcontrolled trial. Pharmacopsychiatry. 2008;41(2):41-47. PubMed doi:10.105/s-207-93210
32. Prudic JM, Sackeim HA, Rifas S. Medication resistance, response to ECT, and prevention of relapse. Psychiatr Ann. 1994;24(5):228-231. doi:10.3928/048-5713-1940501-08
33. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34(2):522-534. PubMed doi:10.1038/np.208.18
34. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012;29(7):587-596. PubMed doi:10.102/da.21969
35. Gaynes BN, Lloyd SW, Lux L, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry. 2014;75(5):477-489, quiz 489. PubMed doi:10.408/JCP.13r0815
36. Kedzior KK, Gellersen HM, Brachetti AK, et al. Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: an exploratory systematic review and metaanalysis. J Affect Disord. 2015;187:73-83. PubMed doi:10.1016/j.jad.2015.08.03
37. Goldberg JF, Freeman MP, Balon R, et al. The American Society of Clinical Psychopharmacology survey of psychopharmacologists' practice patterns for the treatment of mood disorders. Depress Anxiety. 2015;32(8):605-613. PubMed doi:10.102/da.2378
38. Holtzheimer PE 3rd, Russo J, Claypoole KH, et al. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depress Anxiety. 2004;19(1):24-30. PubMed doi:10.102/da.10147
39. Brakemeier EL, Luborzewski A, Danker-Hopfe H, et al. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res. 2007;41(5):395-403. PubMed doi:10.1016/j.jpsychires.206.01.013
40. Berlim MT, Van den Eynde F, Daskalakis ZJ. Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials. Depress Anxiety. 2013;30(7):614-623. PubMed doi:10.102/da.2060
41. Grunhaus L, Schreiber S, Dolberg OT, et al. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry. 2003;53(4):324-331. PubMed doi:10.1016/S06-323(02)0149-3
42. Fregni F, Marcolin MA, Myczkowski M, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2006;9(6):641-654. PubMed doi:10.1017/S14614570506280
43. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63(12):1337-1344. PubMed doi:10.101/archpsyc.63.12.137
44. George MS, Raman R, Benedek DM, et al. A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients. Brain Stimulat. 2014;7(3):421-431. PubMed doi:10.1016/j.brs.2014.03.06
45. Donaldson AE, Gordon MS, Melvin GA, et al. Addressing the needs of adolescents with treatment resistant depressive disorders: a systematic review of rTMS. Brain Stimulat. 2014;7(1):7-12. PubMed doi:10.1016/j.brs.2013.09.012
46. Wall CA, Croarkin PE, Sim LA, et al. Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry. 2011;72(9):1263-1269. PubMed doi:10.408/JCP.1m0703
47. Kim DR, Epperson N, Paré E, et al. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health (Larchmt). 2011;20(2):255-261. PubMed doi:10.1089/jwh.2010.2353
48. Harel EV, Zangen A, Roth Y, et al. H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study. World J Biol Psychiatry. 2011;12(2):119-126. PubMed doi:10.3109/1562975.2010.510893
49. Mantovani A, Aly M, Dagan Y, et al. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. J Affect Disord. 2013;144(1-2):153-159. PubMed doi:10.1016/j.jad.2012.05.038
50. Mantovani A, Simpson HB, Fallon BA, et al. Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatmentresistant obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2010;13(2):217-227. PubMed doi:10.1017/S1461457090435
51. Mantovani A, Simeon D, Urban N, et al. Temporo-parietal junction stimulation in the treatment of depersonalization disorder. Psychiatry Res. 2011;186(1):138-140. PubMed doi:10.1016/j.psychres.2010.08.02
52. Karsen EF, Watts BV, Holtzheimer PE III. Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder. Brain Stimulat. 2014;7(2):151-157. PubMed doi:10.1016/j.brs.2013.10.06
53. Barr MS, Farzan F, Tran LC, et al. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimulat. 2012;5(3):337-346. PubMed doi:10.1016/j.brs.201.06.03
54. Rossi S, Hallett M, Rossini PM, et al; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008-2039. PubMed doi:10.1016/j.clinph.209.08.016
55. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108(1):1-16. PubMed doi:10.1016/S0168-597(97)096-8
56. Keel JC, Smith MJ, Wassermann EM. A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol. 2001;112(4):720. PubMed doi:10.1016/S138-2457(0)0518-6
57. Hsieh TH, Dhamne SC, Chen JJ, et al. Minimal heating of aneurysm clips during repetitive transcranial magnetic stimulation. Clin Neurophysiol. 2012;123(7):1471-1473. PubMed doi:10.1016/j.clinph.201.10.048
58. Tope WD, Shellock FG. Magnetic resonance imaging and permanent cosmetics (tattoos): survey of complications and adverse events. J Magn Reson Imaging. 2002;15(2):180-184. PubMed doi:10.102/jmri.1049
59. Laux P, Tralau T, Tentschert J, et al. A medicaltoxicological view of tattooing. Lancet. 2016;387(10016):395-402. PubMed doi:10.1016/S0140-6736(15)60215-X
60. Deng ZD, Lisanby SH, Peterchev AV. Transcranial magnetic stimulation in the presence of deep brain stimulation implants: induced electrode currents. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:6821-6824. PubMed
61. Deng ZD, Lisanby SH, Peterchev AV. Electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs. Brain Stimulat. 2013;6(1):1-13. PubMed doi:10.1016/j.brs.2012.02.05
62. Philip NS, Carpenter SL, Carpenter LL. Safe use of repetitive transcranial magnetic stimulation in patients with implanted vagus nerve stimulators. Brain Stimulat. 2014;7(4):608-612. PubMed doi:10.1016/j.brs.2014.04.01
63. Hadley D, Anderson BS, Borckardt JJ, et al. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011;27(1):18-25. PubMed doi:10.1097/YCT.0b013e3181ce1a8c
64. Epstein CM, Davey KR. Iron-core coils for transcranial magnetic stimulation. J Clin Neurophysiol. 2002;19(4):376-381. PubMed doi:10.1097/04691-202080-010
65. Roth Y, Zangen A, Hallett M. A coil design for transcranial magnetic stimulation of deep brain regions. J Clin Neurophysiol. 2002;19(4):361-370. PubMed doi:10.1097/04691-202080-08
66. Deng ZD, Lisanby SH, Peterchev AV. Coil design considerations for deep transcranial magnetic stimulation. Clin Neurophysiol. 2014;125(6):1202-1212. PubMed doi:10.1016/j.clinph.2013.1.038
67. Thielscher A, Kammer T. Electric field properties of two commercial figure-8 coils in TMS: calculation of focality and efficiency. Clin Neurophysiol. 2004;115(7):1697-1708. PubMed doi:10.1016/j.clinph.204.02.019
68. McDonald WM, Durkalski V, Ball ER, et al. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011;28(11):973-980. PubMed doi:10.102/da.2085
69. Chen J, Zhou C, Wu B, et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials. Psychiatry Res. 2013;210(3):1260-1264. PubMed doi:10.1016/j.psychres.2013.09.07
70. George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. Am J Psychiatry. 2011;168(4):356-364. PubMed doi:10.176/api.ajp.2010.1060864
71. Speer AM, Wassermann EM, Benson BE, et al. Antidepressant efficacy of high and low frequency rTMS at 110% of motor threshold versus sham stimulation over left prefrontal cortex. Brain Stimulat. 2014;7(1):36-41. PubMed doi:10.1016/j.brs.2013.07.04
72. Berlim MT, Van den Eynde F, Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and shamcontrolled trials. Neuropsychopharmacology. 2013;38(4):543-551. PubMed doi:10.1038/np.2012.237
73. Jin Y, Phillips B. A pilot study of the use of EEGbased synchronized Transcranial Magnetic Stimulation (sTMS) for treatment of Major Depression. BMC Psychiatry. 2014;14:13. PubMed doi:10.186/1471-24X-14-13
74. Leuchter AF, Cook IA, Feifel D, et al. Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. Brain Stimulat. 2015;8(4):787-794. PubMed doi:10.1016/j.brs.2015.05.05
75. Avery DH, Isenberg KE, Sampson SM, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry. 2008;69(3):441-451. PubMed doi:10.408/JCP.v69n0315
76. Slotema CW, Blom JD, Hoek HW, et al. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? a meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71(7):873-884. PubMed doi:10.408/JCP.08m04872gre
77. Gorelick DA, Zangen A, George MS. Transcranial magnetic stimulation in the treatment of substance addiction. Ann N Y Acad Sci. 2014;1327:79-93. PubMed
78. Holtzheimer PE 3rd, McDonald WM, Mufti M, et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety. 2010;27(10):960-963. PubMed doi:10.102/da.20731
79. Awiszus F. On relative frequency estimation of transcranial magnetic stimulation motor threshold. Clin Neurophysiol. 2012;123(11):2319-2320. PubMed doi:10.1016/j.clinph.2012.04.014
80. Westin GG, Bassi BD, Lisanby SH, et al; New York State Psychiatric Institute. Determination of motor threshold using visual observation overestimates transcranial magnetic stimulation dosage: safety implications. Clin Neurophysiol. 2014;125(1):142-147. PubMed doi:10.1016/j.clinph.2013.06.187
81. Pridmore S, Fernandes Filho JA, Nahas Z, et al. Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method. J ECT. 1998;14(1):25-27. PubMed doi:10.1097/0124509-198030-04
82. Padberg F, Zwanzger P, Thoma H, et al. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res. 1999;88(3):163-171. PubMed doi:10.1016/S0165-1781(9)092-X
83. Mufti MA, Holtzheimer PE 3rd, Epstein CM, et al. Bupropion decreases resting motor threshold: a case report. Brain Stimulat. 2010;3(3):177-180. PubMed doi:10.1016/j.brs.209.08.01
84. Zarkowski P, Navarro R, Pavlicova M, et al. The effect of daily prefrontal repetitive transcranial magnetic stimulation over several weeks on resting motor threshold. Brain Stimulat. 2009;2(3):163-167. PubMed doi:10.1016/j.brs.209.02.01
85. Boroojerdi B, Meister IG, Foltys H, et al. Visual and motor cortex excitability: a transcranial magnetic stimulation study. Clin Neurophysiol. 2002;113(9):1501-1504. PubMed doi:10.1016/S138-2457(02)0198-0
86. Johnson KA, Baig M, Ramsey D, et al. Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimulat. 2013;6(2):108-117. PubMed doi:10.1016/j.brs.2012.02.03
87. Ahdab R, Ayache SS, Brugières P, et al. Comparison of "standard" and "navigated" procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression. Neurophysiol Clin. 2010;40(1):27-36. PubMed doi:10.1016/j.neucli.2010.01.01
88. Herwig U, Fallgatter AJ, Höppner J, et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry. 2007;191:441-448. PubMed doi:10.192/bjp.bp.106.034371
89. Beam W, Borckardt JJ, Reeves ST, et al. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimulat. 2009;2(1):50-54. PubMed doi:10.1016/j.brs.208.09.06
90. Mir-Moghtadaei A, Caballero R, Fried P, et al. Concordance between BeamF3 and MRIneuronavigated target sites for repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex. Brain Stimulat. 2015;8(5):965-973. PubMed doi:10.1016/j.brs.2015.05.08
91. Herwig U, Padberg F, Unger J, et al. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry. 2001;50(1):58-61. PubMed doi:10.1016/S06-323(01)0153-2
92. Fitzgerald PB, Hoy K, McQueen S, et al. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology. 2009;34(5):1255-1262. PubMed doi:10.1038/np.208.23
93. Herwig U, Satrapi P, Schönfeldt-Lecuona C. Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 2003;16(2):95-99. PubMed doi:10.1023/B:BRAT.063.93597.9d
94. Greer TL, Trivedi MH. Optimization of treatment algorithms for clinical depression: glutamate antagonists and transcranial magnetic stimulation as case examples. Psychopharmacology: Evidence and Treatments. 2014;12(2):146-151. doi:10.176/api.focus.12.2.146
95. McClintock SM, Husain MM, Wisniewski SR, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011;31(2):180-186. PubMed doi:10.1097/JCP.0b013e31820ebd2c
96. Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend. 2007; 88(suppl 2):S61-S71. PubMed doi:10.1016/j.drugalcdep.207.01.07
97. McClintock SM, Haley C, Bernstein IH. Psychometric considerations of depression symptom rating scales. Neuropsychiatry. 2011;1(6):611-623. doi:10.217/npy.1.59
98. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. PubMed doi:10.1016/S06-323(02)0186-8
99. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. PubMed doi:10.1046/j.1525-1497.201.01609606.x
100. Taylor JJ, Borckardt JJ, George MS. Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia. Pain. 2012;153(6):1219-1225. PubMed doi:10.1016/j.pain.2012.02.030
101. Borckardt JJ, Nahas ZH, Teal J, et al. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the doubleblind phase of the OPT-TMS Trial. Brain Stimulat. 2013;6(6):925-928. PubMed doi:10.1016/j.brs.2013.04.09
102. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9(4):373-380. PubMed doi:10.1016/S1474-42(10)7054-5
103. Trevino K, McClintock SM, Husain MM. The use of topical lidocaine to reduce pain during repetitive transcranial magnetic stimulation for the treatment of depression. J ECT. 2011;27(1):44-47. PubMed doi:10.1097/YCT.0b013e3181f581c
104. Borckardt JJ, Smith AR, Hutcheson K, et al. Reducing pain and unpleasantness during repetitive transcranial magnetic stimulation. J ECT. 2006;22(4):259-264. PubMed doi:10.1097/01.yct.024248.4062.9a
105. Dolberg OT, Schreiber S, Grunhaus L. Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biol Psychiatry. 2001;49(5):468-470. PubMed doi:10.1016/S06-323(0)01086-6
106. Costello AH. Guidance for Industry and Food and Drug Administrative Staff: Class II Special Controls Guidance Document: Repetitive Transcranial Magnetic Stimulation (rTMS) Systems. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration; 2011.
107. Reti IM, Schwarz N, Bower A, et al. Transcranial magnetic stimulation: a potential new treatment for depression associated with traumatic brain injury. Brain Inj. 2015;29(7-8):789-797. PubMed doi:10.3109/0269052.2015.109168
108. Romme JJ, van Dijk N, Boer KR, et al. Diagnosing vasovagal syncope based on quantitative history-taking: validation of the Calgary Syncope Symptom Score. Eur Heart J. 2009;30(23):2888-2896. PubMed doi:10.1093/eurheartj/ehp314
109. Classen J, Witte OW, Schlaug G, et al. Epileptic seizures triggered directly by focal transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol. 1995;94(1):19-25. PubMed doi:10.1016/013-4694(94)0249-K
110. Mann JJ. The medical management of depression. N Engl J Med. 2005;353(17):1819-1834. PubMed doi:10.1056/NEJMra050730
111. Mantovani A, Pavlicova M, Avery D, et al. Longterm efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety. 2012;29(10):883-890. PubMed doi:10.102/da.21967
112. Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014;75(12):1394-1401. PubMed doi:10.408/JCP.13m0897
113. Philip NS, Dunner DL, Dowd SM, et al. Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? a prospective, 12-month multisite randomized pilot study. Brain Stimulat. 2016;9(2):251-257. PubMed doi:10.1016/j.brs.2015.1.07
114. Guidi J, Tomba E, Fava GA. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry. 2016;173(2):128-137. PubMed doi:10.176/api.ajp.2015.15040476
115. Bockting CL, Hollon SD, Jarrett RB, et al. A lifetime approach to major depressive disorder: the contributions of psychological interventions in preventing relapse and recurrence. Clin Psychol Rev. 2015;41:16-26. PubMed doi:10.1016/j.cpr.2015.02.03
116. Kuyken W, Warren FC, Taylor RS, et al. Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trails. JAMA Psychiatry. 2016;73(6):565-574. PubMed doi:10.101/jamapsychiatry.2016.076
117. Trivedi MH, Greer TL, Church TS, et al. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry. 2011;72(5):677-684. PubMed doi:10.408/JCP.10m06743
118. Galletly C, Fitzgerald P, Clarke P, et al. A practical guide to setting up a repetitive transcranial magnetic stimulation (rTMS) service. Australas Psychiatry. 2010;18(4): 314-317. PubMed doi:10.3109/103985610368671